| |
[摘要]：Background: Coronary and peripheral artery diseases are highly prevalent diseases, which are characterised by an unmet medical need in the more advanced stages of disease. These comprise the need for vessel regeneration using therapeutic angiogenic gene therapy as well as the prevention of restenosis post-angioplasty using local gene therapy. Both problems have been addressed by extensive research. Objective: Therefore, this article reviews the patents for therapeutic strategies using gene therapy for the prevention of restenosis and induction of therapeutic angiogenesis in the years 1994 - 2008. Methods: Current publications, websites and patents of a number of potentially suitable gene constructs are reviewed. Conclusion: Cardiovascular gene therapy, particularly in therapeutic angiogenesis, has quietly made its way to the first Phase III approval gene therapy trial. There are chances for more gene constructs to reach this stage. |
|
